Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women (STRATHEGE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00745212|
Recruitment Status : Completed
First Posted : September 3, 2008
Last Update Posted : November 9, 2017
The venous thromboembolism is one of the first causes of maternal mortality. Until 2003, only a few recommendations were available on the optimal use of antithrombotic therapy as a preventive measure against thromboembolism in pregnant women. In this study, we propose :
- To gather the experts who took part in the French consensus conference and the local experts to create a score in accordance with the national and international consensus and to give some precise therapeutic strategies.
To evaluate the discriminant, feasible and useful character of this new score by a prospective multicentric study including 2000 pregnant women with a risk of thromboembolism or placental vascular pathology who will benefit from therapeutic strategies defined by the new score.
|Condition or disease|
|Placental Vascular Pathologies Venous Thromboembolism Diseases|
|Study Type :||Observational|
|Actual Enrollment :||2280 participants|
|Official Title:||Prospective Multicentric Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women With a Risk of Thromboembolism and/or a Risk of Placental Vascular Complication, Strategy Determined With a Risk Score.|
|Study Start Date :||June 2008|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||June 2013|
- Occuring of symptomatic thromboembolic events and/or placental vascular pathology, any other pregnancy pathology requiring hospitalization, any complications from the antithrombotic treatment [ Time Frame: first, second or third trimester during pregnancy or post-partum ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00745212
|Service de Gynécologie Obstétrique - CHU Saint-Etienne|
|Saint-Etienne, France, 42055|
|Principal Investigator:||Céline CHAULEUR, MD PhD||CHU de Saint-Etienne|